Invivyd, Inc. (IVVD) vs Upstream Bio, Inc. (UPB)
Invivyd, Inc. and Upstream Bio, Inc. are both Biotechnology companies. Invivyd, Inc. and Upstream Bio, Inc. are of similar size ($283.2M and $274.1M). Invivyd, Inc. grew revenue faster over the last twelve months: 26.3% against 16.0%. Invivyd, Inc. has the higher net margin (−183.9% vs −4,955.7%) and the higher return on invested capital (−334.9% vs −1,100.9%). Across the 16 metrics below, Invivyd, Inc. leads on 10 and Upstream Bio, Inc. on 6.
Valuation
Profitability
| Metric | IVVD | UPB | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.23% | 100.00% | 65.16% |
| Operating margin | (192.81%) | (5,382.65%) | 0.00% |
| Net margin | (183.90%) | (4,955.67%) | 0.00% |
| Free cash flow margin | (187.88%) | (4,317.42%) | 0.00% |
| Return on equity | (95.89%) | (46.05%) | (57.72%) |
| Return on assets | (69.69%) | (44.61%) | (49.22%) |
| Return on invested capital | (334.92%) | (1,100.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack